Ultragenyx Pharmaceutical Inc. RARE
Set alert
16.37 USD +0.26 +1.65%
As of Nov 2, 1:32 PM ET
15.85 Day range 16.39
12.73 52-week range 39.89
- YTD
- -28.85%
- 1 year
- -52.70%
- Open
- 16.29
- Prev close
- 16.10
- Mkt cap
- 1.61B
- Vol
- 1.15M
- Avg vol
- 4.21M
- EPS
- -5.82
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 15.85
- High
- 16.39
- Forward P/E
- 71.30
- Beta
- 0.35
- Short ratio
- 3.79
- Inst. own
- 118.43%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2026
- 50-d avg
- 17.20
- 200-d avg
- 22.94
- 1y target
- 26.25
Peers
Companies in the same industry
| Symbol | Name | Last | Change | Change % | YTD | Market cap |
|---|---|---|---|---|---|---|
| BMRN | BioMarin Pharmaceutical Inc. | 58.23 | -0.28 | -0.48% | -2.02% | 11.28B |
| FOLD | Amicus Therapeutics, Inc. | 14.49 | 0.00 | 0.00% | +1.76% | 4.55B |
| ESPR | Esperion Therapeutics, Inc. | 3.18 | 0.00 | 0.00% | -14.05% | 661.15M |
| LXRX | Lexicon Pharmaceuticals, Inc. | 1.45 | +0.03 | +2.11% | +26.09% | 642.96M |
| ALXN | Alexion Pharmaceuticals, Inc. | 182.50 | 0.00 | 0.00% | — | — |